Results

Total Results: 320 records

Showing results for "executive".

281. Aspirin Use to Prevent Cardiovascular Disease and Colorectal Cancer: Updated Evidence Report and Systematic Review for the USPSTF (pdf file)
     www.uspreventiveservicestaskforce.org/home/getfilebytoken/whbbEX529Ha4FyvsYv6uh6
     April 26, 2022 - Gaziano JM, Brotons C, Coppolecchia R, et al; ARRIVE Executive Committee.

282. Evidence Summary: Hormone Therapy in Postmenopausal Persons: Primary Prevention of Chronic Conditions | United States Preventive Services Taskforce
     www.uspreventiveservicestaskforce.org/uspstf/document/final-evidence-summary28/menopausal-hormone-therapy-preventive-medication
     November 01, 2022 - Executive summary of the Stages of Reproductive Aging Workshop + 10: addressing the unfinished agenda

283. Aspirin Use to Prevent Cardiovascular Disease and Colorectal Cancer: Updated Evidence Report and Systematic Review for the USPSTF (pdf file)
     www.uspreventiveservicestaskforce.org/home/getfilebytoken/2GDCmTe7akyrAHsTMbfz72
     May 06, 2022 - Gaziano JM, Brotons C, Coppolecchia R, et al; ARRIVE Executive Committee.

284. Nz Rqwxmmr8Vym-Yjuqru- (pdf file)
     www.uspreventiveservicestaskforce.org/home/getfilebytoken/NZ_RQWxMMR8Vym-yJuqru-
     May 23, 2019 - Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel

285. Screening for Carotid Artery Stenosis: An Update of the Evidence (pdf file)
     www.uspreventiveservicestaskforce.org/home/getfilebytoken/YSj5xRQc9DroH8gpUYsoFA
     December 01, 2007 - Executive Commit- tee for the Asymptomatic Carotid Atherosclerosis Study. JAMA. 1995;273: 1421-8.

286. Archived: Final Evidence Summary: Carotid Artery Stenosis: Screening, December 2007 | United States Preventive Services Taskforce
     www.uspreventiveservicestaskforce.org/uspstf/document/final-evidence-summary11/carotid-artery-stenosis-screening-december-2007
     December 15, 2007 - Executive Committee for the Asymptomatic Carotid Atherosclerosis Study. JAMA 1995;273:1421-8.

287. Evidence Summary: Aspirin Use to Prevent Preeclampsia and Related Morbidity and Mortality: Preventive Medication | United States Preventive Services Taskforce
     www.uspreventiveservicestaskforce.org/uspstf/document/final-evidence-summary/low-dose-aspirin-use-for-the-prevention-of-morbidity-and-mortality-from-preeclampsia-preventive-medication
     September 28, 2021 - Share to Facebook Share to X Share to WhatsApp Share to Email Print Evidence Summary Aspirin Use to Prevent Preeclampsia and Related Morbidity and Mortality: Preventive Medication September 28, 2021 Recommendations made by the USPSTF are independ…

288. Hormone Therapy for the Primary Prevention of Chronic Conditions in Postmenopausal Persons: Updated Evidence Report and Systematic Review for the US Preventive Services Task Force (pdf file)
     www.uspreventiveservicestaskforce.org/home/getfilebytoken/Rn7dRezgMx5syB-erQKoKt
     November 01, 2022 - Executive summary of the Stages of Reproductive Aging Workshop + 10: addressing the unfinished agenda

289. Screening for Breast Cancer: U.S. Preventive Services Task Force Recommendation Statement (pdf file)
     www.uspreventiveservicestaskforce.org/home/getfilebytoken/pth_4-Mnau_pZubaefDvUk
     January 01, 2020 - Well-Woman Task Force: components of the well-woman visit—executive summary.

290. Archived: Evidence Summary: Diabetes Mellitus (Type 2) in Adults: Screening, 2003 | United States Preventive Services Taskforce
     www.uspreventiveservicestaskforce.org/uspstf/document/evidence-summary/diabetes-mellitus-type-2-in-adults-screening-2003
     February 03, 2003 - Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel

291. Archived: Final Evidence Summary: Obesity in Adults: Screening and Management | United States Preventive Services Taskforce
     www.uspreventiveservicestaskforce.org/uspstf/document/final-evidence-summary38/obesity-in-adults-screening-and-management-2012
     October 15, 2011 - Finer N; Executive Steering Committee of the Sibutramine Cardiovascular Outcome Trial.

292. Archived: C-Reactive Protein as a Risk Factor for Coronary Heart Disease: A Systematic Review and Meta-analyses for the U.S. Preventive Services Task Force: Coronary Heart Disease: Screening Using Non-Traditional Risk Factors | United States Preventive Services Taskforce
     www.uspreventiveservicestaskforce.org/uspstf/document/c-reactive-protein-as-a-risk-factor-for-coronary-heart-disease-a-systematic-review-and-meta-analyses-for-the-us-preventive-services-task-force/coronary-heart-disease-screening-using-non-traditional-risk-factors
     July 15, 2008 - archived C-Reactive Protein as a Risk Factor for Coronary Heart Disease: A Systematic Review and Meta-analyses for the U.S. Preventive Services Task Force Coronary Heart Disease: Screening Using Non-Traditional Risk Factors July 15, 2008 Recommendations made by the USPSTF are independent of the U.S. …

293. Evidence Summary: Speech and Language Delay and Disorders in Children Age 5 and Younger: Screening | United States Preventive Services Taskforce
     www.uspreventiveservicestaskforce.org/uspstf/document/evidence-summary30/speech-and-language-delay-and-disorders-in-children-age-5-and-younger-screening
     July 07, 2015 - Share to Facebook Share to X Share to WhatsApp Share to Email Print Evidence Summary Speech and Language Delay and Disorders in Children Age 5 and Younger: Screening July 07, 2015 Recommendations made by the USPSTF are independent of the U.S…

294. Archived: Evidence Summary: Speech and Language Delay and Disorders in Children Age 5 and Younger: Screening | United States Preventive Services Taskforce
     www.uspreventiveservicestaskforce.org/uspstf/document/evidence-summary30/speech-and-language-delay-and-disorders-in-children-age-5-and-younger-screening-july-2015
     July 07, 2015 - Share to Facebook Share to X Share to WhatsApp Share to Email Print archived Evidence Summary Speech and Language Delay and Disorders in Children Age 5 and Younger: Screening July 07, 2015 Recommendations made by the USPSTF are independent…

295. Archived: C-Reactive Protein as a Risk Factor for Coronary Heart Disease: A Systematic Review and Meta-analyses for the U.S. Preventive Services Task Force: Coronary Heart Disease: Screening Using Non-Traditional Risk Factors | United States Preventive Services Taskforce
     www.uspreventiveservicestaskforce.org/uspstf/document/c-reactive-protein-as-a-risk-factor-for-coronary-heart-disease-a-systematic-review-and-meta-analyses-for-the-us-preventive-services-task-force/coronary-heart-disease-screening-using-non-traditional-risk-factors-2009
     July 15, 2008 - Share to Facebook Share to X Share to WhatsApp Share to Email Print archived C-Reactive Protein as a Risk Factor for Coronary Heart Disease: A Systematic Review and Meta-analyses for the U.S. Preventive Services Task Force Coronary Heart Disease: S…

296. Evidence Summary: Sexually Transmitted Infections: Behavioral Counseling | United States Preventive Services Taskforce
     www.uspreventiveservicestaskforce.org/uspstf/document/final-evidence-summary/sexually-transmitted-infections-behavioral-counseling
     August 18, 2020 - Share to Facebook Share to X Share to WhatsApp Share to Email Print Evidence Summary Sexually Transmitted Infections: Behavioral Counseling August 18, 2020 Recommendations made by the USPSTF are independent of the U.S. government. They should …

297. Archived: Breast Cancer: Screening | United States Preventive Services Taskforce
     www.uspreventiveservicestaskforce.org/uspstf/recommendation/breast-cancer-screening-january-2016
     January 11, 2016 - Well-Woman Task Force: components of the well-woman visit—executive summary.

298. Effectiveness of Primary Care–Relevant Treatments for Obesity in Adults: A Systematic Evidence Review for the USPSTF (pdf file)
     www.uspreventiveservicestaskforce.org/home/getfilebytoken/hbSopN6uA9u-4EQuKtRGDP
     October 01, 2011 - Finer N; Executive Steering Committee of the Sibutramine Cardiovascu- lar Outcome Trial.

299. C-Reactive Protein as a Risk Factor for Coronary Heart Disease: A Systematic Review and Meta-analyses for the U.S. Preventive Services Task Force (pdf file)
     www.uspreventiveservicestaskforce.org/home/getfilebytoken/khUSqr94jqWPErt9ZRnQ95
     October 01, 2009 - C-Reactive Protein as a Risk Factor for Coronary Heart Disease: A Systematic Review and Meta-analyses for the U.S. Preventive Services Task Force C-Reactive Protein as a Risk Factor for Coronary Heart Disease: A Systematic Review and Meta-analyses for the U.S. Preventive Services Task Force David I. Buckley, MD, MPH;…

300. Archived: Evidence Summary: Breast and Ovarian Cancer: BRCA Genetic Testing, September 2005 | United States Preventive Services Taskforce
     www.uspreventiveservicestaskforce.org/uspstf/document/evidence-summary/breast-cancer--brca-testing-ovarian-cancer-screeni
     September 15, 2005 - Genetic susceptibility to breast and ovarian cancer: assessment, counseling, and testing guidelines executive